These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 29819)
1. Flufenamic acid inhibition of PGE2 production by rectal mucosa in ulcerative colitis. Rachmilewitz D; Ligumsky M; Sharon P; Karmeli F; Zor U Gastroenterology; 1978 Nov; 75(5):929-30. PubMed ID: 29819 [No Abstract] [Full Text] [Related]
2. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Sharon P; Ligumsky M; Rachmilewitz D; Zor U Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669 [TBL] [Abstract][Full Text] [Related]
3. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Ligumsky M; Karmeli F; Sharon P; Zor U; Cohen F; Rachmilewitz D Gastroenterology; 1981 Sep; 81(3):444-9. PubMed ID: 6114012 [TBL] [Abstract][Full Text] [Related]
8. Relationship between rectal mucosal prostaglandin production and water and electrolyte transport in ulcerative colitis. Rampton DS; Sladen GE Digestion; 1984; 30(1):13-22. PubMed ID: 6149163 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease: the in vitro effect of sulphasalazine and other agents on prostaglandin synthesis by human rectal mucosa. Pacheco S; Hillier K; Smith CL Braz J Med Biol Res; 1987; 20(2):221-30. PubMed ID: 2891390 [TBL] [Abstract][Full Text] [Related]
10. [Prostacyclin (PGI2) activity in the rectal mucosa of patients with ulcerative colitis (author's transl)]. Seyfried H; Sinzinger H; Silberbauer K Wien Klin Wochenschr; 1980 Apr; 92(8):282-4. PubMed ID: 6773249 [TBL] [Abstract][Full Text] [Related]
11. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis. Rampton DS; Sladen GE Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788 [TBL] [Abstract][Full Text] [Related]
12. The ubiquitous prostaglandins and their role in ulcerative colitis. Kimberg DV Gastroenterology; 1978 Oct; 75(4):748-50. PubMed ID: 30671 [No Abstract] [Full Text] [Related]
13. Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs. Pacheco S; Hillier K; Smith CL Braz J Med Biol Res; 1990; 23(12):1323-34. PubMed ID: 1983789 [TBL] [Abstract][Full Text] [Related]
15. Rectal electrolyte transport and mucosal permeability in ulcerative colitis and Crohn's disease. Rask-Madsen J; Hammersgaard EA; Knudsen E J Lab Clin Med; 1973 Mar; 81(3):342-53. PubMed ID: 4631401 [No Abstract] [Full Text] [Related]
16. Mechanism of sulphasalazine action in ulcerative colitis. Rachmilewitz D; Sharon P; Ligumsky M; Zor U Lancet; 1978 Oct; 2(8096):946. PubMed ID: 81963 [No Abstract] [Full Text] [Related]
17. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Eliakim R; Karmeli F; Razin E; Rachmilewitz D Gastroenterology; 1988 Nov; 95(5):1167-72. PubMed ID: 2901995 [TBL] [Abstract][Full Text] [Related]
18. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro. Hillier K; Mason PJ; Pacheco S; Smith CL Br J Pharmacol; 1982 May; 76(1):157-61. PubMed ID: 6123357 [TBL] [Abstract][Full Text] [Related]
19. [Contact pH of the rectal mucosa in patient with ulcerative colitis]. Yamazaki Y; Fukushima T; Kawamoto M; Sugita A; Suwa H; Tsuchiya S Nihon Shokakibyo Gakkai Zasshi; 1986 Feb; 83(2):165-9. PubMed ID: 3702134 [No Abstract] [Full Text] [Related]
20. Inhibition of prostaglandin synthetase in human rectal mucosa. Hawkey CJ; Lo Casto M Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]